Skip to content

Nephropathy in Patients With Sickle Cell Disease

Pattern of Sickle Cell Nephropathy in Patients With Sickle Cell Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03680547
Enrollment
25
Registered
2018-09-21
Start date
2020-05-01
Completion date
2021-01-01
Last updated
2019-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle Cell Nephropathy

Brief summary

There are some diseases that give rise to diverse renal manifestations as does sickle cell disease

Detailed description

Such involvement adversely affects virtually all major physiological processes in the kidney, and leads to complications that are common and chronic on the one hand (such as impaired urinary concentrating ability), and those that are rare and uniformly fatal on the other (such as renal medullary carcinoma) This steady adverse renal sequelae shortens the average lifespan of patients with SCD. Proteinuria and a reduced glomerular filtration rate are risk factors associated with increased mortality among those patients with approximately 16-18% of overall mortality in this patient group is due to kidney disease. Once end stage renal disease is reached, the mortality of patients who are on haemodialysis and have SCD is increased severalfold relative to the mortality of patients who are on haemodialysis but do not have SCD. Thus,although the average lifespan of patients with SCD has increased during recent decades owing to improved management of complications outside the kidney,kidney disease contributes substantially to the still increased mortality in SCD.

Interventions

OTHERpatient with sickle cell disease

assess degree of renal affection in patientswith sickle cell disease attending Assuit university Children hospital by estimating some predictors of glomerular and tubular dysfunction.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
5 Months to 18 Years
Healthy volunteers
No

Inclusion criteria

* All patients with sickle cell anemia attending the unit will be included in the study.

Exclusion criteria

* patient with any underlaying systemic diseases other than sickle cell anaemia

Design outcomes

Primary

MeasureTime frameDescription
sickle cell nephropathy in patient with sickle cell diseaseone yeardetection of renal impairment in patients with sickle cell disease by estamating gloerular and tubular dysfunction clinicaly and laboratory

Contacts

Primary Contactfahim mohamed fahim
fahim.osman@med.aun.edu.eg01002500073
Backup Contactahlam badawi ali
ahlam.badawi@med.aun.edu.eg01006807866

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026